Your browser doesn't support javascript.
loading
Subgenomic flavivirus RNA as key target for live-attenuated vaccine development.
Doets, Kristel; Pijlman, Gorben P.
Affiliation
  • Doets K; Wageningen University and Research, Laboratory of Virology, Wageningen, the Netherlands.
  • Pijlman GP; Wageningen University and Research, Laboratory of Virology, Wageningen, the Netherlands.
J Virol ; 98(7): e0010023, 2024 Jul 23.
Article in En | MEDLINE | ID: mdl-38808973
ABSTRACT
Live-attenuated flavivirus vaccines confer long-term protection against disease, but the design of attenuated flaviviruses does not follow a general approach. The non-coding, subgenomic flavivirus RNA (sfRNA) is produced by all flaviviruses and is an essential factor in viral pathogenesis and transmission. We argue that modulating sfRNA expression is a promising, universal strategy to finetune flavivirus attenuation for developing effective flavivirus vaccines of the future.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / Vaccines, Attenuated / Viral Vaccines / Flavivirus Infections / Flavivirus Limits: Animals / Humans Language: En Journal: J Virol / J. virol / Journal of virology Year: 2024 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA, Viral / Vaccines, Attenuated / Viral Vaccines / Flavivirus Infections / Flavivirus Limits: Animals / Humans Language: En Journal: J Virol / J. virol / Journal of virology Year: 2024 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos